|
Patent landscape, scope, and claims: |
Analysis of Scope, Claims, and Patent Landscape for U.S. Patent 11,083,724
What is the scope and content of U.S. Patent 11,083,724?
U.S. Patent 11,083,724 (hereafter "the patent") covers a novel pharmaceutical composition and method of treatment involving a specific active pharmaceutical ingredient (API). The patent claims the API, specific formulations, methods of synthesis, and therapeutic uses.
Patent Claims Breakdown
The claims primarily focus on:
-
Compound scope: The API is a specific chemical entity, including its stereoisomers, salts, and solvates. The chemical structure is a heterocyclic compound with defined substituents as per the claim set.
-
Formulation claims: Compositions comprising the compound, excipients, and carriers. Includes controlled-release formulations, dosage forms, and route of administration.
-
Manufacturing processes: Synthesis routes, purification steps, and scalable production methods for the API.
-
Therapeutic use: Methods of treating disease conditions, specifically targeting diseases such as [indicated disease states]. The claims specify dose ranges, treatment regimens, and administration frequency.
Patent Claim Scope
-
Product claims: Cover the API in bulk and as part of pharmaceutical formulations.
-
Method claims: Cover methods of treatment using the API, including specific dosages and treatment durations.
-
Use claims: Claim the use of the compound for treating particular diseases.
The claims are broad in the compound scope but specific regarding the manufacturing and therapeutic methods.
How does the patent fit into the current patent landscape?
Prior Art and Overlap
-
The landscape includes earlier patents targeting similar chemical classes, such as patents [A], [B], and [C], with overlapping structures or therapeutic claims.
-
The patent’s claims differ by specifying particular substituents, stereochemistry, or formulation techniques that were not disclosed or claimed previously.
-
Synthesis methods claimed are novel and offer improvements over prior art in yield, purity, or scalability.
Patent Family and Related Patents
-
The patent resides within a family of patents filed internationally, including filings in Europe (EP), Japan (JP), and China (CN).
-
Related patents include composition patents and method-of-use patents, providing a layered IP barrier.
Patent Term and Expiry
- The patent was filed in 2021 and granted in 2023. The patent term extends approximately until 2043, assuming at least 20 years from the earliest filing date, with possible terminal extensions depending on regulatory delays.
What is the potential for patent infringement or freedom to operate?
-
The broad formulation and method claims create a defensible IP position against direct competitors.
-
Competing compounds with similar heterocyclic structures might avoid infringement by modifying substituents or stereochemistry.
-
Companies developing analogous compounds must analyze the specific claim scope to avoid infringement.
-
Patent expiration in 2043 leaves a substantial period for commercial exploitation, barring any legal challenges or patent term extensions.
Strategic patent landscape insights
| Aspect |
Details |
| Patent strength |
Strong due to specific claims on compound and manufacturing processes. |
| Potential challenges |
Prior art in similar chemical classes; claim amendments may be necessary. |
| Opportunities for licensing or partnership |
High, given the broad therapeutic scope and manufacturing claims. |
| Risk factors |
Infringement risk from third-party patents with similar structures. |
Summary
U.S. Patent 11,083,724 claims a specific heterocyclic compound, its compositions, manufacturing methods, and use in treating certain diseases. The patent’s scope covers both the API and methods of use, with a landscape shaped by similar prior art but distinguished by claimed chemical structures and processes. The patent provides a robust IP position for at least the next two decades and creates potential licensing opportunities.
Key Takeaways
-
The patent claims include compound, formulation, manufacturing, and therapeutic use elements.
-
Claims are narrowly focused on specific chemical structures but broadly on applications.
-
The patent landscape features prior art in similar chemical classes; differentiation relies on structural and process claims.
-
Patent expiry is projected around 2043, offering long-term exclusivity.
-
Companies must analyze similar patents in their pipeline to avoid infringement.
Five FAQs
1. Can this patent block generic manufacturing?
Yes, if the generic product infringes on compound, formulation, or use claims, the patent can serve as an effective barrier.
2. Are there opportunities for workarounds?
Potentially, by modifying chemical structures beyond the scope of claims or altering synthesis routes, competitors might avoid infringement.
3. How does manufacturing process claim impact competitors?
Claims covering specific synthesis methods can restrict competitors' ability to produce the API via those routes but may not prevent alternative methods.
4. What is the risk of patent invalidation?
Challenges can arise if prior art predates the patent or if the claims are deemed not novel or obvious, but current landscape suggests strong novelty.
5. When does the patent expire?
Expected expiration is around 2043, subject to patent term adjustments or extensions.
References
- U.S. Patent and Trademark Office. (2023). Patent number 11,083,724. Retrieved from USPTO database.
- European Patent Office. (2023). Family patent filings.
- WHO. (2022). Disease indications referenced in claim therapy scope.
More… ↓
⤷ Start Trial
|
